Abstract
Compounds (5a-5f) containing acridine and imidazole moieties in one molecular union were synthesized, characterized and screened against Japanese Encephalitis virus (JEV) (P 20778) and Herpes Simplex virus type-1 (HSV-1) (753166) in-vitro and in-vivo, both. Compound (5e) exhibited the highest activity against both the test microbe (50% inhibition) while (5a) was moderately active (30% inhibition).Compound (5f) displayed 40% inhibition of HSV-1. Investigation revealed that 2-hydroxyphenyl substituent at position-4 is a key factor for bioactivity.
Keywords: Acridinium iodides, Imidazole, Acetophenones, Amido-alkylated acridines, Anti-JEV activity, Anti HSV-I activity
Letters in Drug Design & Discovery
Title: Synthesis and Biological Evaluation of a Series of 4-(arylamido/imidoalkyl)- 5-(arylideno- 4-oxo-2-thio-imidazolidinyl)-N-(methyl-phenyl-imino) Acridinium Iodides as Potential Antiviral Agents
Volume: 6 Issue: 4
Author(s): Abha Bishnoi, Rashmi Saxena, Suruchi Singh, Archna Rani, M. N. Joshi and S. K. Bajpai
Affiliation:
Keywords: Acridinium iodides, Imidazole, Acetophenones, Amido-alkylated acridines, Anti-JEV activity, Anti HSV-I activity
Abstract: Compounds (5a-5f) containing acridine and imidazole moieties in one molecular union were synthesized, characterized and screened against Japanese Encephalitis virus (JEV) (P 20778) and Herpes Simplex virus type-1 (HSV-1) (753166) in-vitro and in-vivo, both. Compound (5e) exhibited the highest activity against both the test microbe (50% inhibition) while (5a) was moderately active (30% inhibition).Compound (5f) displayed 40% inhibition of HSV-1. Investigation revealed that 2-hydroxyphenyl substituent at position-4 is a key factor for bioactivity.
Export Options
About this article
Cite this article as:
Bishnoi Abha, Saxena Rashmi, Singh Suruchi, Rani Archna, Joshi N. M. and Bajpai K. S., Synthesis and Biological Evaluation of a Series of 4-(arylamido/imidoalkyl)- 5-(arylideno- 4-oxo-2-thio-imidazolidinyl)-N-(methyl-phenyl-imino) Acridinium Iodides as Potential Antiviral Agents, Letters in Drug Design & Discovery 2009; 6 (4) . https://dx.doi.org/10.2174/157018009788452500
DOI https://dx.doi.org/10.2174/157018009788452500 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Evidence for Neuropsycho-Consequences of COVID-19
Current Neuropharmacology The Role of the Urokinase Receptor in Epilepsy, in Disorders of Language, Cognition, Communication and Behavior, and in the Central Nervous System
Current Pharmaceutical Design Sodium Lauryl Sulfate, a Microbicide Effective Against Enveloped and Nonenveloped Viruses
Current Drug Targets Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry Dysfunctional Adaptive Immunity During Parasitic Infections
Current Immunology Reviews (Discontinued) Pan-Vertebrate Toll-Like Receptors During Evolution
Current Genomics Novel Targets in Multiple Sclerosis: To Oxidative Stress and Beyond
Current Topics in Medicinal Chemistry Anti-Viral Agents in Neurodegenerative Disorders: New Paradigm for Targeting Alzheimer’s Disease
Recent Patents on Anti-Infective Drug Discovery Molecular Imaging with Small Animal PET/CT
Current Medical Imaging The Potential Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Epilepsy Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Levamisole-Induced Leukoencephalopathy in Russia: Analysis of 30 Cases
Current Drug Safety Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Recently Patented Viral Nucleotide Sequences and Generation of Virus-Derived Vaccines
Recent Patents on Anti-Infective Drug Discovery Mechanism by which Regulatory Rheumatoid Factor Prevents Experimental Autoimmune Encephalomyelitis
Endocrine, Metabolic & Immune Disorders - Drug Targets Possible Impact of Microglial Cells and the Monocyte-Macrophage System on Suicidal Behavior
CNS & Neurological Disorders - Drug Targets Recent Advances in the Discovery of Novel Anti-Herpetic Agents from Chinese Herbal Medicines
Current Organic Chemistry Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease
Current Pharmaceutical Design Immune Checkpoint Inhibitors and Neurotoxicity
Current Neuropharmacology Inflammatory Process as a Determinant Factor for the Degeneration of Substantia Nigra Dopaminergic Neurons: Possible Relevance to the Etiology of Parkinsons Disease
Current Medicinal Chemistry - Central Nervous System Agents HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System
Current HIV Research